Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes

INTRODUCTION: Metformin use has recently been observed to decrease both the rate and mortality of breast cancer. Our study was aim to determine whether metformin use is associated with survival in diabetic breast cancer patients by breast cancer subtype and systemic treatment. METHODS: Data from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Jeong, Kwon, Hyunwook, Lee, Jong Won, Kim, Hwa Jung, Lee, Sae Byul, Park, Hee Sung, Sohn, Guiyun, Lee, Yura, Koh, Beom Seok, Yu, Jong Han, Son, Byung Ho, Ahn, Sei Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504447/
https://www.ncbi.nlm.nih.gov/pubmed/25935404
http://dx.doi.org/10.1186/s13058-015-0574-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504447/
https://www.ncbi.nlm.nih.gov/pubmed/25935404
http://dx.doi.org/10.1186/s13058-015-0574-3

Ejemplares similares